The Future of Ketamine and Temper Disorders In 2019, the FDA and European Commission permitted using an esketamine nasal spready under the manufacturer identify Spravato to take care of despair. However, as of 2021, ketamine has not been permitted because of the FDA to deal with depression or other psychological https://peterx578mbp6.wikifordummies.com/user